16 results
8-K
EX-3.1
NRIX
Nurix Therapeutics Inc
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:07pm
as to matters the member reasonably believes are within such other person’s professional or expert competence and who has been selected with reasonable care
DEF 14A
NRIX
Nurix Therapeutics Inc
25 Mar 21
Definitive proxy
6:03am
is an “audit committee financial expert” as defined in Item 407(d)(5)(ii) of Regulation S-K promulgated under the Securities Act. This designation does
424B4
NRIX
Nurix Therapeutics Inc
5 Mar 21
Prospectus supplement with pricing info
4:07pm
of directors has determined that Ms. Gregory is an “audit committee financial expert” as defined in Item 407(d)(5)(ii) of Regulation S-K promulgated under … is appropriate for their needs, objectives and circumstances, and, if necessary, seek expert advice on those matters.
Notice to prospective investors in Japan
DRS
qo3ikhfsqxd9iczbfr5v
22 Feb 21
Draft registration statement
12:00am
10-Q
EX-3.2
5b6 42jrxp1bq
14 Oct 20
Quarterly report
4:02pm
424B4
89mp9b gmdl6wouox
24 Jul 20
Prospectus supplement with pricing info
4:06pm
S-1
EX-10.1
rpmopiq mjds2skpn
2 Jul 20
IPO registration
4:04pm
S-1
jfs21fxj 77m5kq
2 Jul 20
IPO registration
4:04pm
DRS/A
9zavg42 xa1pyifapln
10 Jun 20
Draft registration statement (amended)
12:00am
DRS
etzmcj 1k1lmum9d9
5 May 20
Draft registration statement
12:00am
- Prev
- 1
- Next